FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GEORGE MICHAEL W 		2. Issuer Name and Ticker or Trading Symbol

CorMedix Inc. [ CRMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O CORMEDIX INC., 1430 HIGHWAY 206, SUITE 200 		3. Date of Earliest Transaction (MM/DD/YYYY)

11/14/2016
(Street)

BEDMINSTER, NJ 07921
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock   $0   (1) 11/14/2016   (1)   P      4143   (2)        (1)   (1) Common Stock   4143   $0   4143   D    
Stock Option (Right to buy Common Stock)   $2.11                      (3) 4/5/2024   Common Stock   15000     15000   D    
Stock Option (Right to buy Common Stock)   $2.79                      (4) 2/27/2024   Common Stock   30000     30000   D    
Stock Option (Right to buy Common Stock)   $5.62                      (4) 3/1/2025   Common Stock   50000     50000   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   1847     1847   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   1176     1176   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   2459     2459   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   3125     3125   D    
Stock Option (Right to buy Common Stock)   $1.91                      (4) 2/21/2026   Common Stock   90000     90000   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   3968     3968   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   2767     2767   D    
Phantom Stock   $0   (1)                    (1)   (1) Common Stock   4335     4335   D    

Explanation of Responses:
( 1)  Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
( 2)  These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees.
( 3)  5,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014.
( 4)  These options vest in full on the first anniversary of the date of grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
GEORGE MICHAEL W
C/O CORMEDIX INC.
1430 HIGHWAY 206, SUITE 200
BEDMINSTER, NJ 07921 		X



Signatures
/s/ Alexander M. Donaldson, by Power of Attorney 11/16/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more CorMedix Charts.
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more CorMedix Charts.